Prevencio announced today that patient data demonstrate high accuracy with its artificial intelligence (AI)-driven HART CVE blood test. Kirkland, Washington-based Prevencio presented data at last week’s American College of Cardiology (ACC) Scientific Sessions that suggested that the HART CVE blood test significantly improves the risk classification for patients with diabetes, allowing for more aggressive therapy in […]
Prevencio
Cardiology research breakthroughs you need to know
Recent months have seen a host of important cardiology research breakthroughs related to new cardio devices and diagnostics, tissue engineering and the overall understanding of heart disease and its treatment. For example, a customizable robotic heart sleeve – developed at Harvard University and Boston Children’s Hospital – has demonstrated advantages over other heart assist devices […]
Blood test could accurately diagnose heart disease
A simple blood test could accurately diagnose heart disease in 2 hours, according to new data published by life science company Prevencio. Prevencio researchers and the Massachusetts General Hospital collaborated to develop a clinical and multi-protein blood test that could diagnose obstructions in coronary arteries, leading to the prevention of a heart attack. The blood test, known […]